Delivery Order SPE2DB20D3101-SPE2DB25FRWG4
- Not listed
- The Defense Logistics Agency awarded a $1,837.56 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a completion deadline of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The award carries no set-aside designation, indicating it was competitively awarded. Performance will occur at the vendor's...
- The Defense Logistics Agency awarded a $2,862.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in a 100-count package. This competitively awarded, non-set-aside contract will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. The delivery order represents a child contract action under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,084.20 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. The contract, established under a firm fixed-price delivery order structure, was competitively awarded without set-aside provisions and is scheduled for completion by August 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,816.36 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 100 mg tablets in quantities of 100 units. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the award from its corporate office location. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,864.76 by the Defense Logistics Agency for Nucynta (tapentadol) 75 mg tablets in a quantity of 100 units. This firm fixed-price, non-set-aside contract was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,929.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 50 mg, with an ultimate completion date of June 17, 2025. This non-set-aside competitive award leverages AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,148.57 to AmerisourceBergen Drug Corp for the supply of Nucynta 75 mg tablets (100 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through...
- The Defense Logistics Agency Medical Supply Chain awarded a $4,442.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nucynta (tapentadol) 50mg tablets. This non-set-aside delivery order, with an ultimate completion date of August 12, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $2,450.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 50 mg, with a completion date of June 16, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply framework with the federal government....
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRWG4Delivery Order
The Defense Logistics Agency awarded a $8,112 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 100 mg on September 23, 2025, with completion scheduled for September 24, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains, including pain management medications such as Nucynta. This delivery order continues AmerisourceBergen's consistent role as a primary pharmaceutical supplier to the Department of Defense through the DLA's global pharmaceutical support program, which encompasses military healthcare needs across numerous therapeutic categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 9/23/25 |